<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: High level of microsatellite instability (MSI-H) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is caused by the inactivation of mismatch repair (MMR) genes; however, it is unknown for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with low level MSI (MSI-L) </plain></SENT>
<SENT sid="1" pm="."><plain>The protein complex involving MSH3 preferentially recognizes insertion/deletion loops (IDLs) of two to eight bases and di- and tetranucleotide repeats are affected in the majority of MSI-L <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We selected 10 and eight MSI-L <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> from 228 and 204 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> and <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">hereditary disease</z:e>, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were analyzed for protein expression of MSH3, MSH2, MSH6, MLH1, and PMS2, and for mutations and loss of heterozygosity (LOH) in MSH3 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Four <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showed a markedly reduced MSH3 expression, whereas <z:hpo ids='HP_0000001'>all</z:hpo> 18 tumors had <z:mpath ids='MPATH_458'>normal</z:mpath> expression of the remaining MMR proteins </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-five different sequence variants were identified </plain></SENT>
<SENT sid="6" pm="."><plain>None of these results in a truncated protein, though L902W represents the first constitutional missense mutation in MSH3 predicted to be functional based on conservation among mutS homologues </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> variants have also been found in <z:mpath ids='MPATH_458'>normal</z:mpath> DNA of the patients and in controls </plain></SENT>
<SENT sid="8" pm="."><plain>LOH intragenic to MSH3 was evident for 12 of 16 (75%) informative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Occurrence of sequence variants in <z:mpath ids='MPATH_458'>normal</z:mpath> DNA of the patients and in controls excludes <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> and mutations specific to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patient population, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, the high frequency of LOH as well as the aberrant protein expression in some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> indicates an involvement of MSH3 impairment in MSI-L <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>